Koichi Goto Selected Research

Interstitial Lung Diseases (Interstitial Lung Disease)

7/2015	Efficacy and Safety of Combined Carboplatin, Paclitaxel, and Bevacizumab for Patients with Advanced Non-squamous Non-small Cell Lung Cancer with Pre-existing Interstitial Lung Disease: A Retrospective Multi-institutional Study.
7/2015	Second-line docetaxel for patients with platinum-refractory advanced non-small cell lung cancer and interstitial pneumonia.
3/2015	Vinorelbine and cisplatin in patients with advanced non-small cell lung cancer with interstitial pneumonia.
3/2013	Safety and efficacy of platinum agents plus etoposide for patients with small cell lung cancer with interstitial lung disease.
1/2013	Successful everolimus treatment in a patient with advanced pancreatic neuroendocrine tumor who developed everolimus-induced interstitial lung disease on two occasions: a case report.
9/2010	Severe interstitial lung disease associated with amrubicin treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koichi Goto Research Topics

Disease

100	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 02/2002
91	Neoplasms (Cancer) 05/2022 - 01/2002
31	Lung Neoplasms (Lung Cancer) 04/2022 - 02/2004
22	Adenocarcinoma of Lung 12/2021 - 04/2002
19	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2021 - 12/2006
9	Adenocarcinoma 04/2021 - 11/2004
9	Disease Progression 01/2021 - 01/2013
9	Carcinoma (Carcinomatosis) 11/2019 - 04/2002
9	Neoplasm Metastasis (Metastasis) 06/2017 - 03/2006
7	Neutropenia 01/2020 - 07/2004
6	Febrile Neutropenia 01/2020 - 10/2015
6	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2015 - 09/2010
5	Diarrhea 06/2022 - 12/2010
5	Hypertension (High Blood Pressure) 01/2022 - 05/2010
4	Exanthema (Rash) 01/2022 - 09/2013
4	Nausea 10/2020 - 12/2015
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 06/2012
4	Thymoma (Thymic Carcinoma) 07/2015 - 09/2003
3	Thrombocytopenia (Thrombopenia) 01/2022 - 12/2015
3	Necrosis 01/2021 - 07/2019
3	Vomiting 10/2020 - 01/2018
3	Anorexia 01/2020 - 01/2016
3	Radiation Pneumonitis 01/2020 - 06/2008
3	Colonic Neoplasms (Colon Cancer) 12/2019 - 01/2011
3	Brain Neoplasms (Brain Tumor) 11/2018 - 03/2006
3	Breast Neoplasms (Breast Cancer) 07/2009 - 03/2004
2	Fever (Fevers) 01/2022 - 02/2004
2	Hyponatremia 01/2021 - 01/2020
2	Respiratory Insufficiency (Respiratory Failure) 01/2021 - 09/2010
2	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 05/2016
2	Hemorrhage 05/2020 - 01/2018

Drug/Important Bio-Agent (IBA)

27	Tyrosine Kinase InhibitorsIBA 12/2021 - 12/2008
26	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2006
24	Cisplatin (Platino)FDA LinkGeneric 03/2021 - 02/2002
17	PlatinumIBA 04/2022 - 07/2003
13	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2022 - 09/2013
12	Liposomes (Liposome)IBA 06/2013 - 04/2002
11	Docetaxel (Taxotere)FDA Link 09/2019 - 02/2002
11	Gefitinib (Iressa)FDA Link 10/2018 - 11/2004
9	Bevacizumab (Avastin)FDA Link 01/2022 - 10/2010
9	Carboplatin (JM8)FDA LinkGeneric 03/2021 - 10/2007
9	Vinorelbine (Navelbine)FDA LinkGeneric 01/2021 - 04/2004
9	Dimyristoylphosphatidylcholine (DMPC)IBA 06/2013 - 04/2002
8	Pemetrexed (MTA)FDA Link 04/2021 - 12/2015
8	NivolumabIBA 01/2021 - 01/2016
7	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2016
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2008
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2004
7	CrizotinibIBA 10/2020 - 01/2017
7	Pharmaceutical PreparationsIBA 05/2020 - 01/2002
7	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 06/2013 - 09/2004
6	osimertinibIBA 12/2021 - 11/2019
6	vandetanib (ZD6474)IBA 01/2021 - 07/2013
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2013
6	Irinotecan (Camptosar)FDA LinkGeneric 08/2016 - 01/2002
6	Therapeutic UsesIBA 02/2015 - 01/2011
5	AfatinibIBA 01/2021 - 09/2013
5	Cadherins (E-Cadherin)IBA 01/2021 - 06/2012
5	alectinibIBA 01/2021 - 01/2017
4	selpercatinibIBA 06/2022 - 01/2020
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 06/2022 - 10/2018
4	Alanine Transaminase (SGPT)IBA 06/2022 - 10/2018
4	Phosphotransferases (Kinase)IBA 01/2022 - 12/2015
4	pembrolizumabIBA 04/2021 - 01/2021
4	Paclitaxel (Taxol)FDA LinkGeneric 10/2020 - 10/2007
4	Biological ProductsIBA 01/2020 - 03/2012
3	entrectinibIBA 05/2022 - 01/2020
3	Formaldehyde (Formol)FDA Link 01/2021 - 03/2004
3	AntiemeticsIBA 10/2020 - 01/2018
3	Monoclonal AntibodiesIBA 01/2020 - 10/2010
3	Anaplastic Lymphoma KinaseIBA 01/2019 - 11/2013
3	ezrinIBA 11/2017 - 07/2015
3	amrubicinIBA 01/2017 - 09/2010
3	Etoposide (VP 16)FDA LinkGeneric 08/2016 - 09/2003
3	Docosahexaenoic AcidsIBA 01/2011 - 03/2008
3	MicellesIBA 12/2010 - 07/2009
3	ATP-Binding Cassette Transporters (ABC Transporters)IBA 07/2009 - 03/2004
3	Polysorbates (PSML)FDA Link 07/2008 - 04/2002
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	atezolizumabIBA 07/2021 - 04/2021
2	ParaffinIBA 01/2021 - 12/2008
2	Programmed Cell Death 1 ReceptorIBA 01/2021 - 11/2020
2	NucleotidesIBA 01/2021 - 05/2018
2	B7-H1 AntigenIBA 01/2021 - 07/2020
2	Serine (L-Serine)FDA Link 01/2021 - 12/2018
2	LigandsIBA 11/2020 - 10/2019
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2020 - 01/2018

Therapy/Procedure

52	Drug Therapy (Chemotherapy) 04/2022 - 07/2003
36	Therapeutics 04/2022 - 03/2006
11	Radiotherapy 01/2020 - 03/2005
10	Chemoradiotherapy 01/2020 - 06/2008
7	Combination Drug Therapy (Combination Chemotherapy) 07/2019 - 07/2003
4	Precision Medicine 01/2022 - 07/2020
3	Palliative Care (Palliative Therapy) 04/2022 - 01/2017
3	Proton Therapy 01/2020 - 01/2016
3	Induction Chemotherapy 01/2017 - 03/2005
3	Aftercare (After-Treatment) 02/2015 - 07/2009
2	Immunotherapy 04/2021 - 01/2020
2	Surgical Instruments (Clip) 01/2021 - 07/2020
2	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 07/2019